Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Endo International (ENDP) Needs to Show Upward Inflection in Earnings for Cantor to Become More Positive
-
Cantor Fitzgerald Bullish on Spark Therapeutics (ONCE) Ahead of Important Hemophilia Catalysts
-
Nabriva Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
-
Athenahealth (ATHN) Offer from Elliot 'seems fair' - Cantor
-
BioDelivery Sciences (BDSI) New CEO Removes One Overhang - Cantor Fitzgerald
-
FMI Corporation Advises IEA Services LLC in Merger With M III Acquisition Corp.
-
Form 4 BGC Partners, Inc. For: May 03 Filed by: CANTOR FITZGERALD, L. P.
-
HMS Holdings (HMSY) PT Raised to $19 at Cantor Fitzgerald on 1Q Report; 'Positioned to Reach FY18 Financial Objectives'
-
The Ensign Group Inc. (ENSG) PT Raised to $35 at Cantor Fitzgerald
-
Cantor Fitzgerald Downgrades U.S. Physical Therapy (USPH) to Neutral
-
MSCI Inc. (MSCI) PT Raised to $166 at Cantor Fitzgerald
-
TherapeuticsMD (TXMD) PT Lowered to $26 at Cantor Fitzgerald
-
Ex-Cantor Fitzgerald bond trader acquitted in U.S. of fraud
-
U.S. prosecutors dealt dual setbacks in mortgage bond fraud crackdown
-
MasterCard (MA) PT Raised to $213 at Cantor Fitzgerald
-
Jack Henry (JKHY) PT Raised to $134 at Cantor Fitzgerald
-
Cerner (CERN) PT Lowered to $70 at Cantor Fitzgerald
-
Zoetis Inc. (ZTS) PT Raised to $98 at Cantor Fitzgerald Following Q1 Earnings Report
-
Karyopharm Therapeutics (KPTI) PT Raised to $25 at Cantor Fitzgerald
-
Fidelity National Information Services (FIS) PT Raised to $111 at Cantor Fitzgerald
-
Rigel Pharmaceuticals (RIGL) PT Raised to $9 at Cantor Fitzgerald
-
Fiserv (FISV) PT Raised to $70 at Cantor Fitzgerald
-
Cantor Fitzgerald Upgrades Aetna (AET) to Overweight Citing More Compelling Risk/Reward
-
Cantor Remains Sidelined on HealthStream (HSTM), Says Top Line Growth Outllok Remains Modest
-
Cantor Stays Positive on Jazz Pharmaceuticals (JAZZ), Sees Purchase of PRV As Potentially Useful Tool for Asset Development
-
AxoGen, Inc. (AXGN) PT Raised to $45 at Cantor Fitzgerald
-
Allergen (AGN) PT Lowered to $180 at Cantor Fitzgerald
-
Spark Therapeutics (ONCE) PT Raised to Street High $103 at Cantor Fitzgerald
-
Stryker (SYK) PT Raised to $170 at Cantor Fitzgerald
-
Orchid Island Capital Announces First Quarter 2018 Results
-
Integra LifeSciences (IART) PT Raised to $59 at Cantor Fitzgerald
-
Biogen (BIIB) PT Lowered to $272 at Cantor Fitzgerald
-
Treasury yield milestone may augur changing tide for risk
-
Form 13F-HR CANTOR FITZGERALD INVEST For: Mar 31
-
Evofem Biosciences (EVFM) Plans $40M Offering of Common Stock
-
Evofem Biosciences Announces Proposed Public Offering of Common Stock
-
ProPhotonix Limited - STKR - ProPhotonix Launches New Website
-
Trilogy Metals Closes $28.7 Million Bought Deal Financing
-
Exponent (EXPO) PT Raised to $96 at Cantor Fitzgerald
-
Cantor Fitzgerald Expands into Power, Energy & Infrastructure Investment Banking with the Addition of Kevin Phillips and Hari Chandra
-
R1 RCM Inc (RCM) PT Raised to $10 at Cantor Fitzgerald
-
UPDATE: GW Pharma (GWPH) PT Raised to Street High $205 at Cantor Fitzgerald
-
Arena Pharma (ARNA) PT Raised to $65 at Cantor Fitzgerald
-
Cantor Fitzgerald & Co. Acquires Securities of Connacher Oil and Gas Limited
-
PlacementTracker Publishes Q1 2018 PIPE and Private Placement Markets League Tables
-
Denise Fiacco joins Instinet Quantitative Trading Strategy Group
-
UPDATE: Intuitive Surgical (ISRG) PT Raised to $510 at Cantor Fitzgerald
-
UnitedHealth Group (UNH) PT Raised to $300 at Cantor Fitzgerald on 1Q18 Earnings Beat; 'Strong Start to 2018'
-
Cantor Remains Positive on GW Pharma (GWPH), 'Smooth Sailing Approaching Epidiolex AdCom'
-
UPDATE: Cantor Fitzgerald Downgrades Celldex Therapeutics (CLDX) to Neutral, 'Glemba in Rear View Mirror'

